Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Common Stock | Options Exercise | $252K | +3.12K | +63.01% | $80.66 | 8.07K | Mar 7, 2025 | Direct | |
transaction | XYL | Common Stock | Sale | -$528K | -4.12K | -51.05% | $128.18 | 3.95K | Mar 7, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Non-Qualified Stock Options (Right to Buy) | Options Exercise | $0 | -3.12K | -100% | $0.00 | 0 | Mar 7, 2025 | Common Stock | 3.12K | $80.66 | Direct | F2 |
Id | Content |
---|---|
F1 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,119 Shares were executed at a range of prices from $127.50 to $128.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
F2 | The February 27, 2020 option grant vested 1,030 options on February 27, 2021, 1,029 options on February 27, 2022, and 1,060 options on February 27, 2023. |